Dr Marty Gentry, PHARM D is a
Pharmacist based in Kingston Springs, Tennessee. Dr Marty Gentry is licensed to practice in Tennessee (license number 11668) and his current practice location is
111 West Kingston Springs Road, Suite 103, Kingston Springs, Tennessee. He can be reached at his office (for appointments etc.) via phone at
(615) 952-3690.
NPI number for Dr Marty Gentry is 1487735585 and his current mailing address is 1209 Shelby Ave, Nashville, Tennessee. He
does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1487735585.
Healthcare Provider's Profile
| Full Name | Dr Marty Gentry |
|---|
| Gender | Male |
|---|
| Speciality | Pharmacist |
|---|
| Location | 111 West Kingston Springs Road, Kingston Springs, Tennessee |
|---|
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
|---|
NPI Data:
- NPI Number: 1487735585
- Provider Enumeration Date: 10/17/2006
- Last Update Date: 07/08/2007
Medical Identifiers
Medical identifiers for Dr Marty Gentry such as npi, medicare ID, medicare PIN, medicaid, etc.
| Identifier | Type | State | Issuer |
|---|
| 1487735585 | NPI | - | NPPES |
Medical Taxonomies and Licenses
| Taxonomy | Type | License (State) | Status |
|---|
| 183500000X | Pharmacist | 11668 (Tennessee) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Marty Gentry is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
| Mailing Address | Practice Location Address |
|---|
Dr Marty Gentry, PHARM D
1209 Shelby Ave,
Nashville, TN 37206-3031
Ph: () - | Dr Marty Gentry, PHARM D
111 West Kingston Springs Road, Suite 103,
Kingston Springs, TN 37082
Ph: (615) 952-3690 |
Reviews and Comments